# Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial

> **NCT00678613** · PHASE2,PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences** · enrollment: 250 (estimated)

## Conditions studied

- Spontaneous Bacterial Peritonitis
- Liver Cirrhosis

## Interventions

- **DRUG:** Probiotics and Placebo
- **DRUG:** Probiotics and Norfloxacin

## Key facts

- **NCT ID:** NCT00678613
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2008-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00678613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00678613, "Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00678613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*